// App-Quantinova.ai

197 : Phenotypic characterization of circulating tumor cells (CTCs) from neuroendocrine prostate cancer (NEPC) and metastatic castration-resistant prostate cancer (mCRPC) patients to identify a novel diagnostic algorithm for the presence of NEPC.

Researchers

Presenter

  • Himisha Beltran

Principal Investigators

  • Adam Jendrisak

  • Mark Landers

  • Jessica Louw

  • Rachel Krupa

  • David M. Nanus

  • Scott T. Tagawa

  • Dena Marrinucci

  • Mark A. Rubin

Medical Centers

  • Weill Cornell Medical College, New York, NY

  • Department of Pathology & Laboratory Medicine, Englader Institute for Precision Medicine, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved